{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:07:40Z","timestamp":1786993660093,"version":"build-2736575974"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.lfs.2022.120633","type":"journal-article","created":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T21:57:54Z","timestamp":1652306274000},"page":"120633","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Renoprotective effect of empagliflozin in cafeteria diet-induced insulin resistance in rats: Modulation of HMGB-1\/TLR-4\/NF-\u03baB axis"],"prefix":"10.1016","volume":"301","author":[{"given":"Dina E.","family":"Al-Wakeel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalia H.","family":"El-Kashef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manar A.","family":"Nader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.lfs.2022.120633_bb0005","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s12272-019-01138-9","article-title":"Hypothalamic inflammation and obesity: a mechanistic review","volume":"42","author":"Seong","year":"2019","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.lfs.2022.120633_bb0010","series-title":"Insulin Resistance","author":"Freeman","year":"2021"},{"key":"10.1016\/j.lfs.2022.120633_bb0015","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.neubiorev.2020.11.003","article-title":"The cafeteria diet: a standardized protocol and its effects on behavior","volume":"122","author":"Lalanza","year":"2021","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"12","key":"10.1016\/j.lfs.2022.120633_bb0020","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nrn.2017.130","article-title":"The dopamine motive system: implications for drug and food addiction","volume":"18","author":"Volkow","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"issue":"6","key":"10.1016\/j.lfs.2022.120633_bb0025","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1038\/oby.2011.18","article-title":"Cafeteria diet is a robust model of human metabolic syndrome with liver and adipose inflammation: comparison to high-fat diet","volume":"19","author":"Sampey","year":"2011","journal-title":"Obesity (Silver Spring)"},{"issue":"3","key":"10.1016\/j.lfs.2022.120633_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2019.e01412","article-title":"Cafeteria-diet induced obesity results in impaired cognitive functioning in a rodent model","volume":"5","author":"Lewis","year":"2019","journal-title":"Heliyon"},{"issue":"7","key":"10.1016\/j.lfs.2022.120633_bb0035","first-page":"658","article-title":"Metformin: current knowledge","volume":"19","author":"Nasri","year":"2014","journal-title":"J. Res. Med. Sci."},{"issue":"3","key":"10.1016\/j.lfs.2022.120633_bb0040","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.bbrc.2012.04.052","article-title":"Metformin-induced AMP-activated protein kinase activation regulates phenylephrine-mediated contraction of rat aorta","volume":"421","author":"Sung","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"19","key":"10.1016\/j.lfs.2022.120633_bb0045","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1001\/archinte.168.19.2070","article-title":"Cardiovascular outcomes in trials of oral diabetes medications: a systematic review","volume":"168","author":"Selvin","year":"2008","journal-title":"Arch. Intern. Med."},{"issue":"10","key":"10.1016\/j.lfs.2022.120633_bb0050","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s40265-015-0416-8","article-title":"Therapeutic use of metformin in prediabetes and diabetes prevention","volume":"75","author":"Hostalek","year":"2015","journal-title":"Drugs"},{"issue":"6","key":"10.1016\/j.lfs.2022.120633_bb0055","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1042\/CS20110386","article-title":"Cellular and molecular mechanisms of metformin: an overview","volume":"122","author":"Viollet","year":"2012","journal-title":"Clin. Sci. (Lond.)"},{"issue":"15","key":"10.1016\/j.lfs.2022.120633_bb0060","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1007\/s40265-014-0298-1","article-title":"Empagliflozin: a review of its use in patients with type 2 diabetes mellitus","volume":"74","author":"Scott","year":"2014","journal-title":"Drugs"},{"issue":"10","key":"10.1016\/j.lfs.2022.120633_bb0065","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s40265-018-0937-z","article-title":"Empagliflozin: a review in type 2 diabetes","volume":"78","author":"Frampton","year":"2018","journal-title":"Drugs"},{"issue":"6","key":"10.1016\/j.lfs.2022.120633_bb0070","doi-asserted-by":"crossref","first-page":"380","DOI":"10.5455\/medarh.2017.71.380-384","article-title":"Assessment of pharmacological responses to an anti-diabetic drug in a new obese type 2 diabetic rat model","volume":"71","author":"Murai","year":"2017","journal-title":"Med. Arch."},{"issue":"1","key":"10.1016\/j.lfs.2022.120633_bb0075","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12933-019-0964-4","article-title":"Empagliflozin, a sodium glucose co-transporter-2 inhibitor, alleviates atrial remodeling and improves mitochondrial function in high-fat diet\/streptozotocin-induced diabetic rats","volume":"18","author":"Shao","year":"2019","journal-title":"Cardiovasc. Diabetol."},{"issue":"2","key":"10.1016\/j.lfs.2022.120633_bb0080","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/00006676-199303000-00010","article-title":"Physiological characteristics of spontaneously developed diabetes in male WBN\/Kob rat and prevention of development of diabetes by chronic oral administration of synthetic trypsin inhibitor (FOY-305)","volume":"8","author":"Shimoda","year":"1993","journal-title":"Pancreas"},{"issue":"1","key":"10.1016\/j.lfs.2022.120633_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.sla.0000102989.54824.fc","article-title":"Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease","volume":"239","author":"Rubino","year":"2004","journal-title":"Ann. Surg."},{"issue":"6","key":"10.1016\/j.lfs.2022.120633_bb0090","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin. Chem."},{"issue":"2","key":"10.1016\/j.lfs.2022.120633_bb0095","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","article-title":"Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction","volume":"95","author":"Ohkawa","year":"1979","journal-title":"Anal. Biochem."},{"issue":"2","key":"10.1016\/j.lfs.2022.120633_bb0100","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0006-291X(72)80218-3","article-title":"The occurrence of superoxide anion in the reaction of reduced phenazine methosulfate and molecular oxygen","volume":"46","author":"Nishikimi","year":"1972","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.lfs.2022.120633_bb0105","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0003-9861(59)90090-6","article-title":"Tissue sulfhydryl groups","volume":"82","author":"Ellman","year":"1959","journal-title":"Arch. Biochem. Biophys."},{"issue":"2","key":"10.1016\/j.lfs.2022.120633_bb0110","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/clinchem\/26.2.227","article-title":"Use of 3,5-dichloro-2-hydroxybenzenesulfonic acid\/4-aminophenazone chromogenic system in direct enzymic assay of uric acid in serum and urine","volume":"26","author":"Fossati","year":"1980","journal-title":"Clin. Chem."},{"issue":"6 Pt 1","key":"10.1016\/j.lfs.2022.120633_bb0115","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1093\/clinchem\/41.6.892","article-title":"Nitrite and nitrate determinations in plasma: a critical evaluation","volume":"41","author":"Moshage","year":"1995","journal-title":"Clin. Chem."},{"issue":"3","key":"10.1016\/j.lfs.2022.120633_bb0120","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1093\/ckj\/sfaa009","article-title":"Structural and ultrastructural renal lesions in rats fed high-fat and high-phosphorus diets","volume":"14","author":"Esquinas","year":"2021","journal-title":"Clin. Kidney J."},{"key":"10.1016\/j.lfs.2022.120633_bb0125","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.lfs.2022.120633_bb0130","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.physbeh.2016.09.029","article-title":"A physiological characterization of the cafeteria diet model of metabolic syndrome in the rat","volume":"167","author":"Gomez-Smith","year":"2016","journal-title":"Physiol. Behav."},{"issue":"2","key":"10.1016\/j.lfs.2022.120633_bb0135","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0896-6273(02)00969-8","article-title":"The need to feed: homeostatic and hedonic control of eating","volume":"36","author":"Saper","year":"2002","journal-title":"Neuron"},{"issue":"5","key":"10.1016\/j.lfs.2022.120633_bb0140","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.physbeh.2009.03.011","article-title":"The relationship between dietary energy density and energy intake","volume":"97","author":"Rolls","year":"2009","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.lfs.2022.120633_bb0145","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.freeradbiomed.2013.06.022","article-title":"Cafeteria diet induces obesity and insulin resistance associated with oxidative stress but not with inflammation: improvement by dietary supplementation with a melon superoxide dismutase","volume":"65","author":"Carillon","year":"2013","journal-title":"Free Radic. Biol. Med."},{"issue":"2","key":"10.1016\/j.lfs.2022.120633_bb0150","doi-asserted-by":"crossref","first-page":"E215","DOI":"10.1152\/ajpendo.00098.2010","article-title":"Cafeteria diet-induced insulin resistance is not associated with decreased insulin signaling or AMPK activity and is alleviated by physical training in rats","volume":"299","author":"Brandt","year":"2010","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.lfs.2022.120633_bb0155","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1021\/jf405239p","article-title":"Grape-seed procyanidins prevent the cafeteria-diet-induced decrease of glucagon-like peptide-1 production","volume":"62","author":"Gonz\u00e1lez-Abu\u00edn","year":"2014","journal-title":"J. Agric. Food Chem."},{"issue":"1","key":"10.1016\/j.lfs.2022.120633_bb0160","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s12933-018-0762-4","article-title":"Association between insulin resistance and the development of cardiovascular disease","volume":"17","author":"Ormazabal","year":"2018","journal-title":"Cardiovasc. Diabetol."},{"issue":"1","key":"10.1016\/j.lfs.2022.120633_bb0165","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.febslet.2007.11.057","article-title":"Inflammation and insulin resistance","volume":"582","author":"de Luca","year":"2008","journal-title":"FEBS Lett."},{"key":"10.1016\/j.lfs.2022.120633_bb0170","doi-asserted-by":"crossref","first-page":"1875870","DOI":"10.1155\/2018\/1875870","article-title":"Oxidative stress, apoptosis, and mitochondrial function in diabetic nephropathy","volume":"2018","author":"Sifuentes-Franco","year":"2018","journal-title":"Int. J. Endocrinol."},{"issue":"2","key":"10.1016\/j.lfs.2022.120633_bb0175","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.bbrc.2016.03.113","article-title":"Cafeteria diet-induced obesity causes oxidative damage in white adipose","volume":"473","author":"Johnson","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lfs.2022.120633_bb0180","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3389\/fphys.2015.00093","article-title":"Oxidative stress-mediated HMGB1 biology","volume":"6","author":"Yu","year":"2015","journal-title":"Front. Physiol."},{"issue":"12","key":"10.1016\/j.lfs.2022.120633_bb0185","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.imbio.2009.11.001","article-title":"HMGB1 activates nuclear factor-\u03baB signaling by RAGE and increases the production of TNF-\u03b1 in human umbilical vein endothelial cells","volume":"215","author":"Luan","year":"2010","journal-title":"Immunobiology"},{"issue":"7","key":"10.1016\/j.lfs.2022.120633_bb0190","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1167\/iovs.03-0805","article-title":"Effect of NF-kappa B inhibition on TNF-alpha-induced apoptosis in human RPE cells","volume":"45","author":"Yang","year":"2004","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.lfs.2022.120633_bb0195","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2147\/DMSO.S58786","article-title":"Combination of the sodium-glucose cotransporter-2 inhibitor empagliflozin with orlistat or sibutramine further improves the body-weight reduction and glucose homeostasis of obese rats fed a cafeteria diet","volume":"7","author":"Vickers","year":"2014","journal-title":"Diabetes Metab. Syndr. Obes."},{"issue":"2","key":"10.1016\/j.lfs.2022.120633_bb0200","doi-asserted-by":"crossref","DOI":"10.3390\/metabo11020087","article-title":"The effects of SGLT2 inhibitors on lipid metabolism","volume":"11","author":"Szekeres","year":"2021","journal-title":"Metabolites"},{"issue":"26","key":"10.1016\/j.lfs.2022.120633_bb0205","doi-asserted-by":"crossref","first-page":"8364","DOI":"10.3748\/wjg.v20.i26.8364","article-title":"Experimental models of non-alcoholic fatty liver disease in rats","volume":"20","author":"Kucera","year":"2014","journal-title":"World J. Gastroenterol."},{"issue":"12","key":"10.1016\/j.lfs.2022.120633_bb0210","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22126332","article-title":"Empagliflozin improves metabolic and hepatic outcomes in a non-diabetic obese biopsy-proven mouse model of advanced NASH","volume":"22","author":"Perakakis","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.lfs.2022.120633_bb0215","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1007\/s00125-018-4702-3","article-title":"Empagliflozin is associated with improvements in liver enzymes potentially consistent with reductions in liver fat: results from randomised trials including the EMPA-REG OUTCOME\u00ae trial","volume":"61","author":"Sattar","year":"2018","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.lfs.2022.120633_bb0220","doi-asserted-by":"crossref","first-page":"85","DOI":"10.4103\/ijn.IJN_61_17","article-title":"Obesity and kidney disease: hidden consequences of the epidemic","volume":"27","author":"Kovesdy","year":"2017","journal-title":"Indian J. Nephrol."},{"issue":"6","key":"10.1016\/j.lfs.2022.120633_bb0225","doi-asserted-by":"crossref","first-page":"F1087","DOI":"10.1152\/ajprenal.00340.2016","article-title":"Insulin resistance in chronic kidney disease: a systematic review","volume":"311","author":"Spoto","year":"2016","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"4","key":"10.1016\/j.lfs.2022.120633_bb0230","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1056\/NEJMoa1515920","article-title":"Empagliflozin and progression of kidney disease in type 2 diabetes","volume":"375","author":"Wanner","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.lfs.2022.120633_bb0235","first-page":"384","article-title":"Empagliflozin alleviates renal inflammation and oxidative stress in streptozotocin-induced diabetic rats partly by repressing HMGB1-TLR4 receptor axis","volume":"22","author":"Ashrafi Jigheh","year":"2019","journal-title":"Iran. J. Basic Med. Sci."},{"issue":"3","key":"10.1016\/j.lfs.2022.120633_bb0240","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.apsb.2016.02.004","article-title":"The role of high mobility group box 1 (HMGB1) in the pathogenesis of kidney diseases","volume":"6","author":"Chen","year":"2016","journal-title":"Acta Pharm. Sin. B"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320522003332?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320522003332?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T21:04:24Z","timestamp":1758402264000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320522003332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":48,"alternative-id":["S0024320522003332"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2022.120633","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Renoprotective effect of empagliflozin in cafeteria diet-induced insulin resistance in rats: Modulation of HMGB-1\/TLR-4\/NF-\u03baB axis","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2022.120633","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"120633"}}